Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: Seven cases
Veterinary Dermatology.
MeSH headings : Dogs; Animals; Lupus Erythematosus, Discoid / drug therapy; Lupus Erythematosus, Discoid / veterinary; Lupus Erythematosus, Cutaneous / drug therapy; Lupus Erythematosus, Cutaneous / veterinary; Lupus Erythematosus, Cutaneous / diagnosis; Pyrimidines; Sulfonamides; Dog Diseases / diagnosis
TL;DR:
Oclacitinib may be considered an effective treatment option for different variants of canine CCLE variants due to their rapid inhibition of the action of interferons known to be relevant in the pathogenesis of CCLE.
(via
Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being
(OpenAlex)